At the heart of Smilow Cancer Hospital and Yale Cancer Center, our commitment to safety, compassionate care, and research excellence will always remain.
Patient and Cancer Information
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
The delivery of cancer care is becoming ever more complex, involving multiple disciplines for the diagnosis and treatment of patients. In response, Smilow Cancer Hospital and Yale Cancer Center have developed 13 multidisciplinary clinical centers to care for patients diagnosed with cancer. The clinical centers allow physicians and specialists at Smilow Cancer Hospital to focus their expertise on specific types of cancers enabling them to provide superior care to our patients through a patient-friendly system of care led by a nurse coordinator. Our nationally recognized physicians provide unparalleled cancer expertise and are leaders in both the treatment of cancers and the development of innovative treatment strategies.
The key characteristics of the 13 Clinical Centers at Smilow Cancer Hospital are:
- Patient centered care
- Rapid access to appointments and relevant tests
- Personalized care led by a physician in collaboration with a team of specialists
- Personal communication and assistance from a dedicated intake specialist and nurse coordinator
- Compassion and support for the psychological aspects of cancer
- Rapid communication with and involvement of outside primary care and referring physicians
Ways to stay safe during chemotherapy and immunotherapy.
Latest News
- August 30, 2024
Yale Study Highlights Unmet Needs for Patients With Melanoma Who Progress or Relapse After Immunotherapy Treatment
- August 29, 2024
YCC Publications 2024
- August 29, 2024Source: Medical News Today
New rectal cancer treatment may reduce risk of recurrence, help avoid surgery
- August 29, 2024
Dr. Thejal Srikumar Joins Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center
- August 27, 2024Source: OncLive
Dr. Townsend on the Future Analysis of Prostate Cancer Driver Mutations Using Neoplasm Tissue Samples
- August 26, 2024
Dr. Rachel Greenup on Yale Cancer Answers
- August 26, 2024Source: WWLP 22News
World's first mRNA lung cancer vaccine is now in clinical trials
- August 23, 2024Source: ASCO Post -- American Society of Clinical Oncologists
ASCO Guidelines Updated to Encourage Early Integration of Palliative Care
- August 23, 2024
Dr. Susan Mayne Appointed Professor of Epidemiology (Adjunct) in CDE
- August 23, 2024Source: Everyday Health
‘Boy Meets World’ Actress Diagnosed With Stage 0 Breast Cancer
- August 23, 2024Source: NBC CT
U.S. participates in world's first lung cancer vaccine trials
- August 21, 2024Source: ASBMB Today
ASBMB names 2025 award winners